Skip to main content
. 2014 Dec 8;9:5711–5727. doi: 10.2147/IJN.S74353

Figure 9.

Figure 9

In vivo antitumor efficacy in the MDAMB 231 tumor-bearing mouse model.

Notes: (A) Tumor volume (mm3) profiles according to time (day) are shown. All samples were injected on day 0, 7, and 14 (red arrows). Points indicate the means ± SD (n=5). (B) Body weight (g) was also measured with tumor size measurement for 18 days. Points indicate the means ± SD (n=5). *P<0.05 compared with the control group; #P<0.05 compared with the LHSA5 group; +P<0.05 compared with the Taxotere group.

Abbreviations: LHSA, LMWH-SA; LMWH, low-molecular-weight heparin; SA, stearylamine; DCT, deocetaxel; SD, standard deviation.